Medicine
Memantine 2 mg/mL oral solution
Memantine 2 mg/mL oral solution is a generic prescription medicine for oral use, made by 5 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted between 15° to 30°C (59°to 86°F).
Key facts
- Active ingredient (INN)
- Memantine
- Brand
- Sold under the generic name
- Strength
- 2 mg/mL
- Dosage form
- Oral solution
- Route
- Oral
- Packs
- 240 mL, 1 bottle, 2 trays and 3 more
- Manufacturers
- Macleods PharmaceuticalsIndiaChartwell RXApotexChartwell Governmental & Specialty RXSeton Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted between 15° to 30°C (59°to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N06DX01 Memantine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 13 October 2015
- Identifiers
- RxCUI 996740DailyMed set ID 421f6478-09df-49d3-a7c4-52814b4aa90e, 4076d3ef-d0a9-96c5-1a15-812c1e42929c, 42f0a9f2-4aa4-46fb-bc24-d3df843bb906 +2NDC 13925-540, 60505-6162, 33342-066 +2Application ANDA210319, ANDA209955, ANDA202790 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 240 mL in 1 bottle | 33342-066-28 | Macleods PharmaceuticalsIndia | 13 October 2015 |
| 1 bottle in 1 carton / 360 mL in 1 bottle | 60505-6162-5 | Apotex | 30 April 2018 |
| 2 tray in 1 box / 10 cup in 1 tray / 5 mL in 1 cup | 68999-943-24 | Chartwell Governmental & Specialty RX | 2 February 2026 |
| 2 tray in 1 box / 10 cup in 1 tray / 5 mL in 1 cup | 62135-943-24 | Chartwell RX | 25 February 2025 |
| 240 mL in 1 bottle | 62135-943-37 | Chartwell RX | 27 October 2022 |
| 360 mL in 1 bottle | 13925-540-12 | Seton Pharmaceuticals | 19 May 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Memantine
Clinical summary
Memantine is a N-methyl-D-aspartate receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. It is available as tablets, extended-release capsules and oral solution. MedsAcross supplies Memantine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MemantineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- memantine hydrochloride prescribing information (Actavis Pharma) · U.S. National Library of Medicine, DailyMed
- Axura: European public assessment report (EPAR) · European Medicines Agency
- Ebixa: European public assessment report (EPAR) · European Medicines Agency
Need Memantine 2 mg/mL oral solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.